Trial intelligence / Profile preview

Autologous chondrocyte transplantation protocol validation for cartilage lesions

RBR-6fgy76Phase 1Recruiting

Sponsor
Hospital Israelita Albert Einstein
Start
Nov 2017
Modality
Cell Therapies
Countries
1
01

Overview

Phase 1, open-label, single-arm trial of autologous cultured chondrocytes in cartilage defect, sponsored by Hospital Israelita Albert Einstein. Started Nov 2017; status: recruiting.

02

Drugs

autologous cultured chondrocytes
03

Conditions

cartilage defect

Beyond the preview

Go deeper on RBR-6fgy76.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on RBR-6fgy76.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call